{
    "collection": {
        "version": "1.0",
        "href": "/markup/drupal/abstract,metatags?src=%2Fsgrworks%2Fbook%2F978-0-8261-3778-4%2Fchapter%2Fch16.atom&src=%2Fsgrworks%2Fbook%2F978-0-8261-3778-4.atom&&src=%2Fsgrworks%2Fbook%2F978-0-8261-3778-4%2Fchapter%2Fch16.atom&src=%2Fsgrworks%2Fbook%2F978-0-8261-3778-4.atom",
        "items": [
            {
                "href": "/markup/drupal/abstract?src=%2Fsgrworks%2Fbook%2F978-0-8261-3778-4%2Fchapter%2Fch16.atom&&src=/sgrworks/book/978-0-8261-3778-4/chapter/ch16.atom&src=/sgrworks/book/978-0-8261-3778-4.atom",
                "data": [
                    {
                        "profile-id": "abstract",
                        "mimeType": "application/xhtml+xml",
                        "sourceUri": "/sgrworks/book/978-0-8261-3778-4/chapter/ch16.atom",
                        "markup": "<div xmlns=\"http://www.w3.org/1999/xhtml\" class=\"abstract\"><p class=\"first\" id=\"d2032986e65\">Nasopharyngeal cancer (NPC) is a significant healthcare burden in endemic areas and Epstein–Barr virus (EBV) infection plays a crucial role in pathogenesis. The management has evolved in the past decades to transform this once very deadly cancer to a highly treatable one. Advances in radiation therapy (RT) technique and systemic treatment have substantially improvedthe treatment outcome. Although the prognosis of early NPC is favorable, long-term toxicity and quality of life issues continue to be the major problems of survivorship. On the other hand, patients with locoregionally advanced disease still suffer from a considerable rate of treatment failure and the prognosis is extremely poor for those with distant metastasis. Future research should focus on risk-adapted treatment strategies in order to achieve the ultimate goal of personalized medicine. Immunotherapy is an exciting area to explore and the results of ongoing studies are eagerly awaited.</p></div>"
                    }
                ]
            },
            {
                "href": "/markup/drupal/metatags?src=%2Fsgrworks%2Fbook%2F978-0-8261-3778-4%2Fchapter%2Fch16.atom&&src=/sgrworks/book/978-0-8261-3778-4/chapter/ch16.atom&src=/sgrworks/book/978-0-8261-3778-4.atom",
                "data": [
                    {
                        "profile-id": "metatags",
                        "mimeType": "application/xhtml+xml",
                        "sourceUri": "/sgrworks/book/978-0-8261-3778-4/chapter/ch16.atom",
                        "markup": "<html><meta name=\"HW.identifier\" content=\"/sgrworks/book/978-0-8261-3778-4/chapter/ch16.atom\"></meta><meta name=\"citation_publication_date\" content=\"2018-07-19\"></meta><meta name=\"citation_publisher\" content=\"Springer Publishing Company\"></meta><meta name=\"citation_isbn\" content=\"978-0-8261-3777-7\"></meta><meta name=\"citation_title\" content=\"Nasopharyngeal Cancer\"></meta><meta name=\"citation_author\" content=\"Wai Tong Ng\"></meta><meta name=\"citation_author\" content=\"Oscar S. H. Chan\"></meta><meta name=\"citation_author\" content=\"Henry C. K. Sze\"></meta><meta name=\"citation_author\" content=\"Ka On Lam\"></meta><meta name=\"citation_author\" content=\"Anne W. M. Lee\"></meta><meta name=\"citation_abstract\" content=\"&lt;p&gt;Nasopharyngeal cancer (NPC) is a significant healthcare burden in endemic areas and Epstein–Barr virus (EBV) infection plays a crucial role in pathogenesis. The management has evolved in the past decades to transform this once very deadly cancer to a highly treatable one. Advances in radiation therapy (RT) technique and systemic treatment have substantially improvedthe treatment outcome. Although the prognosis of early NPC is favorable, long-term toxicity and quality of life issues continue to be the major problems of survivorship. On the other hand, patients with locoregionally advanced disease still suffer from a considerable rate of treatment failure and the prognosis is extremely poor for those with distant metastasis. Future research should focus on risk-adapted treatment strategies in order to achieve the ultimate goal of personalized medicine. Immunotherapy is an exciting area to explore and the results of ongoing studies are eagerly awaited.&lt;/p&gt;\"></meta><meta name=\"DC.Created\" content=\"2018-07-19\"></meta><meta name=\"DC.Format\" content=\"text/html\"></meta><meta name=\"DC.Type\" content=\"text\"></meta><meta name=\"DC.Title\" content=\"Nasopharyngeal Cancer\"></meta><meta name=\"DC.Description\" content=\"Nasopharyngeal cancer (NPC) is a significant healthcare burden in endemic areas and Epstein–Barr virus (EBV) infection plays a crucial role in pathogenesis. The management has evolved in the past decades to transform this once very deadly cancer to a highly treatable one. Advances in radiation therapy (RT) technique and systemic treatment have substantially improvedthe treatment outcome. Although the prognosis of early NPC is favorable, long-term toxicity and quality of life issues continue to be the major problems of survivorship. On the other hand, patients with locoregionally advanced disease still suffer from a considerable rate of treatment failure and the prognosis is extremely poor for those with distant metastasis. Future research should focus on risk-adapted treatment strategies in order to achieve the ultimate goal of personalized medicine. Immunotherapy is an exciting area to explore and the results of ongoing studies are eagerly awaited.\"></meta><meta name=\"DC.Publisher\" content=\"Springer Publishing Company\"></meta><meta property=\"og:title\" content=\"Nasopharyngeal Cancer\"></meta><meta property=\"og:type\" content=\"book\"></meta><meta property=\"book:isbn\" content=\"978-0-8261-3777-7\"></meta><meta property=\"book:release_date\" content=\"2018-07-19\"></meta><meta property=\"og:image\" content=\"/sites/default/files/styles/cover_content_metadata/binary/sgrworks/c3b01d77732d4227/46fb39f9e65fb11aff41ca94fea283d8ad2daea600fb33e46d50d737aa08ac5a/cover.jpg\"></meta><meta property=\"og:url\" content=\"/content/book/978-0-8261-3778-4/chapter/ch16\"></meta><meta property=\"og:description\" content=\"Nasopharyngeal cancer (NPC) is a significant healthcare burden in endemic areas and Epstein–Barr virus (EBV) infection plays a crucial role in pathogenesis. The management has evolved in the past decades to transform this once very deadly cancer to a highly treatable one. Advances in radiation therapy (RT) technique and systemic treatment have substantially improvedthe treatment outcome. Although the prognosis of early NPC is favorable, long-term toxicity and quality of life issues continue to be the major problems of survivorship. On the other hand, patients with locoregionally advanced disease still suffer from a considerable rate of treatment failure and the prognosis is extremely poor for those with distant metastasis. Future research should focus on risk-adapted treatment strategies in order to achieve the ultimate goal of personalized medicine. Immunotherapy is an exciting area to explore and the results of ongoing studies are eagerly awaited.\"></meta></html>"
                    }
                ]
            },
            {
                "href": "/markup/drupal/abstract?src=%2Fsgrworks%2Fbook%2F978-0-8261-3778-4.atom&&src=/sgrworks/book/978-0-8261-3778-4/chapter/ch16.atom&src=/sgrworks/book/978-0-8261-3778-4.atom",
                "data": [
                    {
                        "profile-id": "abstract",
                        "mimeType": "application/xhtml+xml",
                        "sourceUri": "/sgrworks/book/978-0-8261-3778-4.atom",
                        "markup": "<div xmlns=\"http://www.w3.org/1999/xhtml\" class=\"abstract\"><p class=\"first\" id=\"d2032703e118\">Head and neck cancers are challenging diseases that require complex management and exemplify the value of collaboration among multiple specialties. Very appropriately, the Editors are representatives of each of the three major treatment modalities. The genesis of this work was driven by recognition that, despite evolution in various approaches and new emerging data, high quality clinical care is optimal when there is mutual respect of each other’s discipline, and when each patient has a treatment recommendation made by multidisciplinary input. When discussing the need for a new textbook the authors recognized and agreed that critical developments have been transforming the field of head and neck oncology. Indeed, in the past few years there have been significant advances in our understanding of the molecular biology, immune evasion, and genetic landscape of head and neck cancers, as well as the multidisciplinary management of these malignancies, including immunotherapy, targeted therapies, precision radiation therapy, robotic surgery, and supportive care capabilities. With the rising epidemic of human papillomavirus-associated oropharyngeal cancer, customizing treatment is of utmost importance, in particular taking into consideration long-term treatment effects. This book captures key advances and aims to become a quick and handy reference tool for head and neck cancer management issues, and features didactic patient cases in each site-specific management chapter. The authors anticipate that physicians involved in the care of these patients will find the material relevant to their clinical practice. Evidence-based approaches are emphasized throughout the textbook. The book consists of four sections. The first section discusses epidemiology, biology, diagnosis, and staging. The second section deals with established and emerging treatment modalities of head and neck cancers. The third section discusses site-specific management. The fourth section deals with recurrent or metastatic disease and the last section discusses supportive care and special patient groups.</p></div>"
                    }
                ]
            },
            {
                "href": "/markup/drupal/metatags?src=%2Fsgrworks%2Fbook%2F978-0-8261-3778-4.atom&&src=/sgrworks/book/978-0-8261-3778-4/chapter/ch16.atom&src=/sgrworks/book/978-0-8261-3778-4.atom",
                "data": [
                    {
                        "profile-id": "metatags",
                        "mimeType": "application/xhtml+xml",
                        "sourceUri": "/sgrworks/book/978-0-8261-3778-4.atom",
                        "markup": "<html><meta name=\"HW.identifier\" content=\"/sgrworks/book/978-0-8261-3778-4.atom\"></meta><meta name=\"citation_publication_date\" content=\"2018-07-24\"></meta><meta name=\"citation_publisher\" content=\"Springer Publishing Company\"></meta><meta name=\"citation_isbn\" content=\"978-0-8261-3777-7\"></meta><meta name=\"citation_title\" content=\"Head and Neck Cancers\"></meta><meta name=\"citation_author\" content=\"Athanassios Argiris\"></meta><meta name=\"citation_author\" content=\"Robert L. Ferris\"></meta><meta name=\"citation_author\" content=\"David I. Rosenthal\"></meta><meta name=\"citation_author\" content=\"Angela L. Mazul\"></meta><meta name=\"citation_author\" content=\"Erich M. Sturgis\"></meta><meta name=\"citation_author\" content=\"Andrew F. Olshan\"></meta><meta name=\"citation_author\" content=\"Jose P. Zevallos\"></meta><meta name=\"citation_author\" content=\"Michelle D. Williams\"></meta><meta name=\"citation_author\" content=\"Adel K. El-Naggar\"></meta><meta name=\"citation_author\" content=\"Steffen Wagner\"></meta><meta name=\"citation_author\" content=\"Jens P. Klussmann\"></meta><meta name=\"citation_author\" content=\"Ruud H. Brakenhoff\"></meta><meta name=\"citation_author\" content=\"Farhoud Faraji\"></meta><meta name=\"citation_author\" content=\"Carole Fakhry\"></meta><meta name=\"citation_author\" content=\"Rathan M. Subramaniam\"></meta><meta name=\"citation_author\" content=\"Jussi Sillanpaa\"></meta><meta name=\"citation_author\" content=\"C. Jillian Tsai\"></meta><meta name=\"citation_author\" content=\"Nancy Y. Lee\"></meta><meta name=\"citation_author\" content=\"Pierre Blanchard\"></meta><meta name=\"citation_author\" content=\"G. Brandon Gunn\"></meta><meta name=\"citation_author\" content=\"Steven J. Frank\"></meta><meta name=\"citation_author\" content=\"Meghan T. Turner\"></meta><meta name=\"citation_author\" content=\"F. Christopher Holsinger\"></meta><meta name=\"citation_author\" content=\"Robert L. Ferris\"></meta><meta name=\"citation_author\" content=\"Glenn J. Hanna\"></meta><meta name=\"citation_author\" content=\"Robert I. Haddad\"></meta><meta name=\"citation_author\" content=\"Jennifer Moy\"></meta><meta name=\"citation_author\" content=\"Jennifer M. Johnson\"></meta><meta name=\"citation_author\" content=\"Jessica Moskovitz\"></meta><meta name=\"citation_author\" content=\"Robert L. Ferris\"></meta><meta name=\"citation_author\" content=\"Athanassios Argiris\"></meta><meta name=\"citation_author\" content=\"Emmanuel Seront\"></meta><meta name=\"citation_author\" content=\"Sandra Schmitz\"></meta><meta name=\"citation_author\" content=\"Jean-Pascal Machiels\"></meta><meta name=\"citation_author\" content=\"Sophie Stock-Martineau\"></meta><meta name=\"citation_author\" content=\"Yanqun Dong\"></meta><meta name=\"citation_author\" content=\"Denis Soulières\"></meta><meta name=\"citation_author\" content=\"Thomas J. Galloway\"></meta><meta name=\"citation_author\" content=\"Christien A. Kluwe\"></meta><meta name=\"citation_author\" content=\"Anthony J. Cmelak\"></meta><meta name=\"citation_author\" content=\"Barbara A. Burtness\"></meta><meta name=\"citation_author\" content=\"Meghan T. Turner\"></meta><meta name=\"citation_author\" content=\"Anirudh Saraswathula\"></meta><meta name=\"citation_author\" content=\"F. Christopher Holsinger\"></meta><meta name=\"citation_author\" content=\"Antoine Eskander\"></meta><meta name=\"citation_author\" content=\"Jacques Bernier\"></meta><meta name=\"citation_author\" content=\"Lisa Licitra\"></meta><meta name=\"citation_author\" content=\"Paolo Bossi\"></meta><meta name=\"citation_author\" content=\"Theodoros N. Teknos\"></meta><meta name=\"citation_author\" content=\"Wai Tong Ng\"></meta><meta name=\"citation_author\" content=\"Oscar S. H. Chan\"></meta><meta name=\"citation_author\" content=\"Henry C. K. Sze\"></meta><meta name=\"citation_author\" content=\"Ka On Lam\"></meta><meta name=\"citation_author\" content=\"Anne W. M. Lee\"></meta><meta name=\"citation_author\" content=\"Moran Amit\"></meta><meta name=\"citation_author\" content=\"Loren K. Mell\"></meta><meta name=\"citation_author\" content=\"Cristina P. Rodriguez\"></meta><meta name=\"citation_author\" content=\"Neil D. Gross\"></meta><meta name=\"citation_author\" content=\"Arlene A. Forastiere\"></meta><meta name=\"citation_author\" content=\"Jae Lee\"></meta><meta name=\"citation_author\" content=\"Steven B. Chinn\"></meta><meta name=\"citation_author\" content=\"Karim Boudadi\"></meta><meta name=\"citation_author\" content=\"Avraham Eisbruch\"></meta><meta name=\"citation_author\" content=\"Randal S. Weber\"></meta><meta name=\"citation_author\" content=\"Heather A. Osborn\"></meta><meta name=\"citation_author\" content=\"Jong Chul Park\"></meta><meta name=\"citation_author\" content=\"Nabil F. Saba\"></meta><meta name=\"citation_author\" content=\"Pierre Blanchard\"></meta><meta name=\"citation_author\" content=\"Derrick T. Lin\"></meta><meta name=\"citation_author\" content=\"Shirin Attarian\"></meta><meta name=\"citation_author\" content=\"Richard Blake Ross\"></meta><meta name=\"citation_author\" content=\"Shlomo A. Koyfman\"></meta><meta name=\"citation_author\" content=\"Missak Haigentz\"></meta><meta name=\"citation_author\" content=\"Cristina P. Rodriguez\"></meta><meta name=\"citation_author\" content=\"Jessica L. Geiger\"></meta><meta name=\"citation_author\" content=\"Jon Mallen-St. Clair\"></meta><meta name=\"citation_author\" content=\"Patrick K. Ha\"></meta><meta name=\"citation_author\" content=\"Sue S. Yom\"></meta><meta name=\"citation_author\" content=\"Adam S. Garden\"></meta><meta name=\"citation_author\" content=\"David J. Adelstein\"></meta><meta name=\"citation_author\" content=\"Antoine Eskander\"></meta><meta name=\"citation_author\" content=\"Sharon A. Spencer\"></meta><meta name=\"citation_author\" content=\"Corey J. Langer\"></meta><meta name=\"citation_author\" content=\"Takashi Maruo\"></meta><meta name=\"citation_author\" content=\"Ryuichi Hayashi\"></meta><meta name=\"citation_author\" content=\"Sadamoto Zenda\"></meta><meta name=\"citation_author\" content=\"James W. Rocco\"></meta><meta name=\"citation_author\" content=\"Tomohiro Enokida\"></meta><meta name=\"citation_author\" content=\"Susumu Okano\"></meta><meta name=\"citation_author\" content=\"Makoto Tahara\"></meta><meta name=\"citation_author\" content=\"Rajesh V. Lalla\"></meta><meta name=\"citation_author\" content=\"Douglas E. Peterson\"></meta><meta name=\"citation_author\" content=\"Katherine A. Hutcheson\"></meta><meta name=\"citation_author\" content=\"Jan S. Lewin\"></meta><meta name=\"citation_author\" content=\"Minh Tam Truong\"></meta><meta name=\"citation_author\" content=\"Lisa Ann Kachnic\"></meta><meta name=\"citation_author\" content=\"Jessica L. Geiger\"></meta><meta name=\"citation_author\" content=\"Julie E. Bauman\"></meta><meta name=\"citation_abstract\" content=\"&lt;p&gt;Head and neck cancers are challenging diseases that require complex management and exemplify the value of collaboration among multiple specialties. Very appropriately, the Editors are representatives of each of the three major treatment modalities. The genesis of this work was driven by recognition that, despite evolution in various approaches and new emerging data, high quality clinical care is optimal when there is mutual respect of each other’s discipline, and when each patient has a treatment recommendation made by multidisciplinary input. When discussing the need for a new textbook the authors recognized and agreed that critical developments have been transforming the field of head and neck oncology. Indeed, in the past few years there have been significant advances in our understanding of the molecular biology, immune evasion, and genetic landscape of head and neck cancers, as well as the multidisciplinary management of these malignancies, including immunotherapy, targeted therapies, precision radiation therapy, robotic surgery, and supportive care capabilities. With the rising epidemic of human papillomavirus-associated oropharyngeal cancer, customizing treatment is of utmost importance, in particular taking into consideration long-term treatment effects. This book captures key advances and aims to become a quick and handy reference tool for head and neck cancer management issues, and features didactic patient cases in each site-specific management chapter. The authors anticipate that physicians involved in the care of these patients will find the material relevant to their clinical practice. Evidence-based approaches are emphasized throughout the textbook. The book consists of four sections. The first section discusses epidemiology, biology, diagnosis, and staging. The second section deals with established and emerging treatment modalities of head and neck cancers. The third section discusses site-specific management. The fourth section deals with recurrent or metastatic disease and the last section discusses supportive care and special patient groups.&lt;/p&gt;\"></meta><meta name=\"DC.Created\" content=\"2018-07-24\"></meta><meta name=\"DC.Format\" content=\"text/html\"></meta><meta name=\"DC.Type\" content=\"text\"></meta><meta name=\"DC.Title\" content=\"Head and Neck Cancers\"></meta><meta name=\"DC.Description\" content=\"Head and neck cancers are challenging diseases that require complex management and exemplify the value of collaboration among multiple specialties. Very appropriately, the Editors are representatives of each of the three major treatment modalities. The genesis of this work was driven by recognition that, despite evolution in various approaches and new emerging data, high quality clinical care is optimal when there is mutual respect of each other’s discipline, and when each patient has a treatment recommendation made by multidisciplinary input. When discussing the need for a new textbook the authors recognized and agreed that critical developments have been transforming the field of head and neck oncology. Indeed, in the past few years there have been significant advances in our understanding of the molecular biology, immune evasion, and genetic landscape of head and neck cancers, as well as the multidisciplinary management of these malignancies, including immunotherapy, targeted therapies, precision radiation therapy, robotic surgery, and supportive care capabilities. With the rising epidemic of human papillomavirus-associated oropharyngeal cancer, customizing treatment is of utmost importance, in particular taking into consideration long-term treatment effects. This book captures key advances and aims to become a quick and handy reference tool for head and neck cancer management issues, and features didactic patient cases in each site-specific management chapter. The authors anticipate that physicians involved in the care of these patients will find the material relevant to their clinical practice. Evidence-based approaches are emphasized throughout the textbook. The book consists of four sections. The first section discusses epidemiology, biology, diagnosis, and staging. The second section deals with established and emerging treatment modalities of head and neck cancers. The third section discusses site-specific management. The fourth section deals with recurrent or metastatic disease and the last section discusses supportive care and special patient groups.\"></meta><meta name=\"DC.Publisher\" content=\"Springer Publishing Company\"></meta><meta property=\"og:title\" content=\"Head and Neck Cancers\"></meta><meta property=\"og:type\" content=\"book\"></meta><meta property=\"book:isbn\" content=\"978-0-8261-3777-7\"></meta><meta property=\"book:release_date\" content=\"2018-07-24\"></meta><meta property=\"og:image\" content=\"/sites/default/files/styles/cover_content_metadata/binary/sgrworks/c3b01d77732d4227/46fb39f9e65fb11aff41ca94fea283d8ad2daea600fb33e46d50d737aa08ac5a/cover.jpg\"></meta><meta property=\"og:url\" content=\"/content/book/978-0-8261-3778-4\"></meta><meta property=\"og:description\" content=\"Head and neck cancers are challenging diseases that require complex management and exemplify the value of collaboration among multiple specialties. Very appropriately, the Editors are representatives of each of the three major treatment modalities. The genesis of this work was driven by recognition that, despite evolution in various approaches and new emerging data, high quality clinical care is optimal when there is mutual respect of each other’s discipline, and when each patient has a treatment recommendation made by multidisciplinary input. When discussing the need for a new textbook the authors recognized and agreed that critical developments have been transforming the field of head and neck oncology. Indeed, in the past few years there have been significant advances in our understanding of the molecular biology, immune evasion, and genetic landscape of head and neck cancers, as well as the multidisciplinary management of these malignancies, including immunotherapy, targeted therapies, precision radiation therapy, robotic surgery, and supportive care capabilities. With the rising epidemic of human papillomavirus-associated oropharyngeal cancer, customizing treatment is of utmost importance, in particular taking into consideration long-term treatment effects. This book captures key advances and aims to become a quick and handy reference tool for head and neck cancer management issues, and features didactic patient cases in each site-specific management chapter. The authors anticipate that physicians involved in the care of these patients will find the material relevant to their clinical practice. Evidence-based approaches are emphasized throughout the textbook. The book consists of four sections. The first section discusses epidemiology, biology, diagnosis, and staging. The second section deals with established and emerging treatment modalities of head and neck cancers. The third section discusses site-specific management. The fourth section deals with recurrent or metastatic disease and the last section discusses supportive care and special patient groups.\"></meta></html>"
                    }
                ]
            }
        ]
    }
}